U.S. Psoriasis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (TNF Inhibitors, Interleukin Inhibitors, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108704

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 7.4% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Drug Class TNF Inhibitors Interleukin Inhibitors Others
	By Type Plaque Psoriasis Psoriatic Arthritis Others
	By Route of Administration Oral Parenteral/Systemic Topical
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies